An HPLC certificate may display a single result such as “99% purity.” The number looks absolute, but it is produced by a particular separation, detector, wavelength, sample preparation, integration method, and calculation. Change those conditions and the percentage can change, even when the sample does not.
The correct first question is not “What is the HPLC purity?” It is “What did this HPLC procedure separate and detect, and how was the percentage calculated?”
HPLC separates; UV detection measures absorbance
High-performance liquid chromatography moves a dissolved sample through a column. Sample components interact differently with the mobile and stationary phases, causing them to elute at different times. A UV detector measures absorbance as material leaves the column.
The chromatogram is a map of detector response over time. Peaks can represent separated components, but one peak is not always one compound:
- two components can co-elute;
- one compound can form more than one detectable species;
- baseline or solvent artifacts can be integrated as peaks;
- an impurity with weak absorbance can produce little area;
- a strongly absorbing impurity can produce disproportionate area.
Chromatography and detection must therefore be evaluated together.
Area percent is not automatically mass percent
A common calculation divides the area of the main peak by the total integrated peak area. That yields area percent under the stated detector conditions.
It equals mass fraction only under assumptions that often are not demonstrated. The main component and every impurity would need suitable and known response behavior, and the method would need to recover, separate, and detect the relevant components.
For peptide-related impurities, UV response can vary with amino-acid composition and detection wavelength. Non-UV-active materials may be invisible. Water, inorganic salts, counterions, and some residual solvents are not represented by a typical peptide HPLC area-percent result.
Thus, “99% by HPLC” does not mean that 99% of the gross vial contents are the target peptide by mass.
Wavelength changes what the detector sees
Peptide methods commonly use low UV wavelengths where the peptide bond absorbs. Low-wavelength detection can be sensitive, but it is also more vulnerable to solvent, additive, and baseline effects. Detection at a higher wavelength may emphasize aromatic residues or other chromophores and can change relative peak areas.
A report should state:
- detection wavelength and bandwidth;
- whether one or multiple channels were recorded;
- detector settings;
- baseline and integration rules;
- whether response factors were applied.
Without the wavelength, a purity percentage is not fully defined.
Co-elution can hide impurities
If an impurity elutes inside the main peak, the detector reports their combined response. A visually sharp main peak does not prove chemical homogeneity.
Specificity can be challenged through:
- spiking known related substances;
- forced-degradation samples;
- changes in column chemistry or mobile phase;
- peak-purity tools used within their limits;
- fraction collection and mass-spectrometric analysis;
- an orthogonal chromatographic method.
USP <621> describes chromatographic principles and system suitability, while ICH Q2(R2) emphasizes that a procedure must be shown suitable for its intended purpose. A purity claim requires more than retention-time agreement.
System suitability is a run-level gate
Before sample results are accepted, the system must show that it can perform the intended separation. Depending on the method, system-suitability criteria can include:
- resolution between critical peaks;
- replicate-injection precision;
- peak tailing;
- column efficiency;
- signal-to-noise or sensitivity;
- retention-time consistency;
- carryover.
A chromatogram without the associated system-suitability results cannot show whether the system was capable of resolving the impurity question on that day.
Passing system suitability does not prove that the method is valid for every sample. It confirms that selected performance checks were met for the run.
Sample preparation can change the result
Concentration, diluent, mixing, filtration, vial material, temperature, and time before injection can affect recovery and stability. Peptides can adsorb to surfaces or form aggregates. A diluent can fail to dissolve all material or can promote degradation.
Independent preparations help reveal variability introduced before the vial reaches the instrument. Repeated injections from the same prepared solution test injection repeatability, not the full analytical procedure.
Eight fields required for an interpretable HPLC report
- Sample identity and lot linkage. The report must identify the exact submitted lot.
- Method version and purpose. Identity, assay, and related-substances procedures are not interchangeable.
- Column and conditions. Column chemistry, dimensions, temperature, mobile phases, gradient, and flow.
- Detector settings. Wavelength, bandwidth, and processing.
- Reference standard. Identity, qualification, potency, and preparation.
- System suitability. Criteria and observed values from the sample sequence.
- Chromatograms and integration. Standards, blanks, samples, reintegration, and excluded peaks.
- Calculation. Area normalization, external standard, response factors, dilution, and amount basis.
What HPLC-UV does not replace
HPLC-UV does not by itself establish intact molecular mass, full sequence, stereochemistry, water, counterion content, residual solvents, elemental impurities, sterility, endotoxin, or biological activity. Those are separate questions requiring suitable methods.
A defensible certificate states a narrow result: for example, that the sample produced a specified main-peak area percentage under a named, validated related-substances method and met defined system-suitability and acceptance criteria.
Primary and authoritative sources
- USP General Chapter <621> Chromatography
- FDA/ICH Q2(R2) Validation of Analytical Procedures
- ICH Q14 Analytical Procedure Development
- FDA/ICH M10 Bioanalytical Method Validation
Related Serum Research pages
This article explains analytical interpretation. It does not certify a laboratory, lot, or product.
Continue reading
Editorial responsibility and corrections
Published by Serum Research. Sources checked October 1, 2026. This is educational material; no independent scientific, clinical, statistical, analytical, or regulatory review is claimed. Read how we review evidence or send a correction.
For Research Use Only. Not for Human Consumption. This page does not provide instructions for medical use or establish the identity, quality, safety, or equivalence of a catalog material.